Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Stanford

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|November 29, 2024
Response to 'Why Japan lacks a vibrant biotech industry'Hiroki Ashida, John Stanford
International Journal of Mycobacteriology|January 21, 2016
Mycobacteria and their worldJohn Stanford, Cynthia Stanford
Journal of the Royal Society of Medicine|October 3, 2002
Immunotherapy for cancerJohn Grange, John Stanford, Cynthia Stanford
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosisJohn Stanford, Cynthia Stanford, John Grange
Immunotherapy|April 6, 2011
Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TBDiana Dlugovitzky, Cynthia Stanford, John Stanford
Immunotherapy|April 6, 2011
Maternal immunization with actinomycetales immunomodulators reduces parasitemias in offspring challenged with Trypanosoma cruziHector Davila, Griselda Didoli, Oscar Bottasso, et al.
Angiology|May 26, 2010
Immunotherapy for the prevention of myointimal hyperplasia after experimental balloon injury of the rat carotid arteryMonica Hansrani, John Stanford, Graham McIntyre, et al.
Respiratory Medicine|November 10, 2005
Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosisDiana Dlugovitzky, Gladys Fiorenza, Miguel Farroni, et al.
Current Pharmaceutical Design|April 10, 2009
The common mycobacterial antigens and their importance in the treatment of diseaseJohn Stanford, Cynthia Stanford, Gerard Stansby, et al.
Innate Immunity|September 24, 2013
Down-regulation of NF-κB signaling by Gordonia bronchialis prevents the activation of gut epithelial cellsPaola L Smaldini, John Stanford, David E Romanin, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|November 29, 2024
Response to 'Why Japan lacks a vibrant biotech industry'Hiroki Ashida, John Stanford
International Journal of Mycobacteriology|January 21, 2016
Mycobacteria and their worldJohn Stanford, Cynthia Stanford
Journal of the Royal Society of Medicine|October 3, 2002
Immunotherapy for cancerJohn Grange, John Stanford, Cynthia Stanford
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosisJohn Stanford, Cynthia Stanford, John Grange
Immunotherapy|April 6, 2011
Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TBDiana Dlugovitzky, Cynthia Stanford, John Stanford
Immunotherapy|April 6, 2011
Maternal immunization with actinomycetales immunomodulators reduces parasitemias in offspring challenged with Trypanosoma cruziHector Davila, Griselda Didoli, Oscar Bottasso, et al.
Angiology|May 26, 2010
Immunotherapy for the prevention of myointimal hyperplasia after experimental balloon injury of the rat carotid arteryMonica Hansrani, John Stanford, Graham McIntyre, et al.
Respiratory Medicine|November 10, 2005
Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosisDiana Dlugovitzky, Gladys Fiorenza, Miguel Farroni, et al.
Current Pharmaceutical Design|April 10, 2009
The common mycobacterial antigens and their importance in the treatment of diseaseJohn Stanford, Cynthia Stanford, Gerard Stansby, et al.
Innate Immunity|September 24, 2013
Down-regulation of NF-κB signaling by Gordonia bronchialis prevents the activation of gut epithelial cellsPaola L Smaldini, John Stanford, David E Romanin, et al.
Pageof 2